A Typical Case of Asherman Syndrome (Fritsch Syndrome) due to Prolonged Retained Fragment of Cu-T in Myometrium

Authors

  • Amera Anjum
  • K. Tabassum

DOI:

https://doi.org/10.37591/rrjom.v7i1.1617

Abstract

Asherman or Fritsch syndrome is also known as intrauterine adhesions. It can lead to partial or complete dysfunction of the endometrium. It affects women of all races and ages equally suggesting no underlying genetic predisposition for its development. The incidence is 40% after D and C. It is mostly due to vigorous curettage of endometrium causes scarring and occlusion in the uterine cavity or it may also be due to pelvic infections. Often, patients experience menstrual irregularities, recurrent abortions and infertility. A female married woman aged about 41 years came to gynaecology OPD, National Institute of Unani Medicine (NIUM) hospital, Bangalore, in 2015 with the complaints of menstrual irregularities and infertility. On the basis of signs, symptoms and imaging techniques such as USG, X-ray, hysteroscopy and laparoscopy, the case was diagnosed as Asherman or Fritsch syndrome due to prolonged retained fragment of Cu-T in the myometrium.

 

Keywords: Asherman syndrome, intrauterine adhesions, menstrual irregularities and infertility, retained Cu-T fragment, X-ray abdomen diagnosis

 

Cite this Article

Amera Anjum, Tabassum K. A Typical Case of Asherman Syndrome (Fritsch Syndrome) due to Prolonged Retained Fragment of Cu-T in Myometrium. Research & Reviews: Journal of Medicine. 2017; 7(1): 10–12p.

Downloads

Published

2019-06-27

Issue

Vol. 7 No. 1 (2017)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.